CCND1 and non-small cell lung carcinoma: Taken together, these results showed that metapristone significantly inhibited the growth of NSCLC cells and remarkably induced the apoptosis by activating caspase-3 pathways, enhancing PTEN protein levels, and reducing PARP and PCNA protein levels, as well as decreasing the protein level of CyclinD1.